Intermediate-term changes in serum 1,5-anhydroglucitol (GlycoMark) predict long-term changes in glycosylated hemoglobin (Alc) in patients with type 1 and 2 diabetes mellitus

被引：0
|
作者：
Sarno, MJ
Cole, TG
Nowatzke, W
McGill, JB
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A106 / A106
页数：1
相关论文
共 50 条
  • [31] 1,5-Anhydroglucitol Is Associated with Early-Phase Insulin Secretion in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus
    Ma, Xiaojing
    Hao, Yaping
    Hu, Xiang
    Luo, Yuqi
    Deng, Zixuan
    Zhou, Jian
    Bao, Yuqian
    Jia, Weiping
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (05) : 320 - 326
  • [32] 1,5-Anhydroglucitol x glycated hemoglobin A1c/100 as a potential biomarker for islet β-cell function among patients with type 2 diabetes
    Su, Hang
    Ma, Xiaojing
    Shen, Yun
    He, Xingxing
    Ying, Lingwen
    Zhu, Wei
    Wang, Yufei
    Bao, Yuqian
    Zhou, Jian
    ACTA DIABETOLOGICA, 2020, 57 (04) : 439 - 446
  • [33] ANALYSIS OF SHORT-TERM CHANGES IN REVERSIBLY AND IRREVERSIBLY GLYCOSYLATED HEMOGLOBIN-A1 - RELEVANCE TO DIABETES-MELLITUS
    BOLLI, G
    COMPAGNUCCI, P
    CARTECHINI, MG
    DEFEO, P
    SANTEUSANIO, F
    BRUNETTI, P
    DIABETOLOGIA, 1981, 21 (01) : 70 - 72
  • [34] Increased 1,5-Anhydroglucitol Predicts Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes Treated with Short-Term Intensive Insulin Therapy
    Liu, Liehua
    Wan, Xuesi
    Liu, Juan
    Huang, Zhimin
    Cao, Xiaopei
    Li, Yanbing
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (09) : 756 - +
  • [35] Association between 1,5-anhydroglucitol and early-phase insulin secretion in Chinese patients with newly diagnosed type 2 diabetes mellitus
    Zhou, Jian
    Ma, Xiaojing
    Su, Hang
    Hao, Yaping
    Hu, Xiang
    Luo, Yuqi
    Deng, Zixuan
    Bao, Yuqian
    Jia, Weiping
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S63 - S63
  • [36] CHRONIC KIDNEY DISEASE IN PATIENTS WITH LONG-TERM TYPE 1 DIABETES MELLITUS
    Yevloyeva, Madina I.
    Arutyunova, Margarita S.
    Severina, Anastasia S.
    Trubitsyna, Natalia P.
    Zaitseva, Natalia V.
    Shamhalova, Minara S.
    Shestakova, Marina V.
    DIABETES MELLITUS, 2023, 26 (06): : 504 - 514
  • [37] 1,5-anhydroglucitol is a good predictor for the treatment effect of the Sodium-Glucose cotransporter 2 inhibitor in Japanese patients with type 2 diabetes mellitus
    Usui, Masahiro
    Tanaka, Mamiko
    Takahashi, Hironori
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2020, 21
  • [38] Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes
    Shen, Yun
    Si, Yiming
    Lu, Jingyi
    Ma, Xiaojing
    Zhang, Lei
    Mo, Yifei
    Lu, Wei
    Zhu, Wei
    Bao, Yuqian
    Hu, Gang
    Zhou, Jian
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [39] Saliva 1,5-anhydroglucitol is associated with early-phase insulin secretion in Chinese patients with type 2 diabetes
    Ying, Lingwen
    Jian, Chaohui
    Ma, Xiaojing
    Ge, Kun
    Zhu, Wei
    Wang, Yufei
    Zhao, Aihua
    Zhou, Jian
    Jia, Wei
    Bao, Yuqian
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [40] Serum 1,5-Anhydroglucitol Concentrations Are a Reliable Index of Glycemic Control in Type 2 Diabetes With Mild or Moderate Renal Dysfunction
    Kim, Won Jun
    Park, Cheol-Young
    Lee, Kyu-Beck
    Park, Se Eun
    Rhee, Eun Jung
    Lee, Won Young
    Oh, Ki Won
    Park, Sung Woo
    DIABETES CARE, 2012, 35 (02) : 281 - 286
12345